Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 3/20 | 1.00 |
| ▸ | HPGD | P15428 | 4/20 | 0.77 |
| ▸ | NPC1 | O15118 | 2/20 | 0.77 |
| ▸ | CES2 | O00748 | 6/20 | 0.65 |
| ▸ | CES1 | P23141 | 5/20 | 0.65 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.64 |
| ▸ | MEN1 | O00255 | 3/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.61 |
| ▸ | MAPT | P10636 | 5/20 | 0.61 |
| ▸ | LMNA | P02545 | 1/20 | 0.60 |
| ▸ | GAA | P10253 | 1/20 | 0.60 |
| ▸ | GFER | P55789 | 1/20 | 0.60 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.58 |
| ▸ | KCNK3 | O14649 | 1/20 | 0.57 |
| ▸ | CASP3 | P42574 | 1/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.56 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.56 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.56 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.56 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30671562 | 0.98 | RAB9A (0.96) | RAB9AHPGDNPC1CES2CES1 | |
| Michler'S Ketone SCHEMBL10883748 | 0.94 | RAB9A (0.89) | RAB9AHPGDNPC1CES2CES1 | |
| SCHEMBL194888 | 0.91 | RAB9A (0.83) | RAB9AHPGDNPC1CES2CES1 | |
| SCHEMBL28230346 | 0.87 | HPGD (1.00) | RAB9AHPGDNPC1KMT2AMEN1 | |
| SCHEMBL43585 | 0.87 | HPGD (1.00) | RAB9AHPGDNPC1KMT2AMEN1 | |
| Michler'S Ketone SCHEMBL3324670 | 0.87 | HPGD (1.00) | RAB9AHPGDNPC1KMT2AMEN1 | |
| SCHEMBL25803102 | 0.85 | RAB9A (0.73) | RAB9AHPGDNPC1CES2CES1 | |
| Hydrochloric Acid SCHEMBL10950983 | 0.85 | HPGD (0.96) | RAB9AHPGDNPC1KMT2AMEN1 | |
| SCHEMBL4174554 | 0.84 | RAB9A (0.73) | RAB9AHPGDNPC1KMT2AMEN1 | |
| Benzil SCHEMBL1422480 | 0.84 | CES2 (0.78) | RAB9AHPGDNPC1CES2CES1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1300132-A2 | Agent for dyeing keratinous fibres | Henkel Kommanditgesellschaft auf Aktien (DE) | 2003-04-09 | — | — | EP | claimed |
| WO-2023220463-A1 | METHODS OF FORMING AN OBJECT IN A VOLUME OF A PHOTOHARDENABLE COMPOSITION | QUADRATIC 3D, INC. (US) | 2023-11-16 | — | — | WO | disclosed |
| CN-112920065-B | Benzil compound and preparation method and application thereof | 上海中医药大学 | 2023-04-25 | — | — | CN | disclosed |
| CN-102906215-B | Photochromic material | MITSUBISHI GAS CHEMICAL CO | 2014-11-05 | — | — | CN | disclosed |
| CN-102906215-A | Photochromic material | MITSUBISHI GAS CHEMICAL CO | 2013-01-30 | — | — | CN | disclosed |
| CN-101371197-B | Photosensitive dry film resist, printed wiring board making use of the same, and process for producing printed wiring board | KANEKA CORP | 2012-12-26 | — | — | CN | disclosed |
| EP-2397468-A1 | NOVEL CROSSLINKED HEXAARYL BISIMIDAZOLE COMPOUND AND DERIVATIVE THEREOF, METHOD FOR PRODUCING THE COMPOUND AND PRECURSOR COMPOUND TO BE USED IN THE PRODUCTION METHOD | Abe, Jiro (JP) | 2011-12-21 | — | — | EP | disclosed |
| EP-2397468-A1 | NOVEL CROSSLINKED HEXAARYL BISIMIDAZOLE COMPOUND AND DERIVATIVE THEREOF, METHOD FOR PRODUCING THE COMPOUND AND PRECURSOR COMPOUND TO BE USED IN THE PRODUCTION METHOD | Abe, Jiro (JP) | 2011-12-21 | — | — | EP | disclosed |
| US-20110306743-A1 | NOVEL CROSSLINKED HEXAARYL BISIMIDAZOLE COMPOUND AND DERIVATIVE THEREOF, METHOD FOR PRODUCING THE COMPOUND AND PRECURSOR COMPOUND TO BE USED IN THE PRODUCTION METHOD | KANTO KAGAKU KABUSHIKI KAISHA (JP) | 2011-12-15 | — | — | US | disclosed |
| US-20110306743-A1 | NOVEL CROSSLINKED HEXAARYL BISIMIDAZOLE COMPOUND AND DERIVATIVE THEREOF, METHOD FOR PRODUCING THE COMPOUND AND PRECURSOR COMPOUND TO BE USED IN THE PRODUCTION METHOD | KANTO KAGAKU KABUSHIKI KAISHA (JP) | 2011-12-15 | — | — | US | disclosed |
| US-4721734-A | PHOTOPOLYMERIZATION OF UNSATURATED COMPOUNDS | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1988-01-26 | — | — | US | disclosed |
| US-4598076-A | 2-pyrrolin-3-carbonitril-derivatives, pharmaceutical compositions containing them and their anti-inflammatory and ulcer protective activity | WARNER-LAMBERT COMPANY (US) | 1986-07-01 | — | — | US | disclosed |
| EP-0091045-B1 | 2-PYRROLINE-3-CARBONITRILE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND MEDICINES CONTAINING THEM | GÖDECKE AKTIENGESELLSCHAFT (DE) | 1986-02-26 | — | — | EP | disclosed |
| US-4517185-A | 2-Pyrrolin-3-carbonitrile derivatives, and pharmaceutical compositions containing them and their anti-inflammatory and ulcer protective activity | WARNER-LAMBERT COMPANY (US) | 1985-05-14 | — | — | US | disclosed |
| US-4477681-A | PHOTOPOLYMERIZATION AND HARDENING OF PRINTING DYES | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1984-10-16 | — | — | US | disclosed |
| EP-0091045-A1 | 2-Pyrroline-3-carbonitrile derivatives, process for their preparation and medicines containing them | GÖDECKE AKTIENGESELLSCHAFT (DE) | 1983-10-12 | — | — | EP | disclosed |
| US-4167566-A | Antithrombotic 2-prenyl-3-oxo-5,6-diaryl-as-triazenes | PIERRE FABRE, S.A. (FR) | 1979-09-11 | — | — | US | disclosed |
| US-4008232-A | ANTIINFLAMMATORY | ELI LILLY AND COMPANY (US) | 1977-02-15 | — | — | US | disclosed |
| US-3979516-A | Anti-inflammatory 3-amino-5,6-diaryl-1,2,4-triazines | ELI LILLY AND COMPANY (US) | 1976-09-07 | — | — | US | disclosed |
| US-3948894-A | ANTIINFLAMMATORY | ELI LILLY AND COMPANY (US) | 1976-04-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110306743-A1 | NOVEL CROSSLINKED HEXAARYL BISIMIDAZOLE COMPOUND AND DERIVATIVE THEREOF, METHOD FOR PRODUCING THE COMPOUND AND PRECURSOR COMPOUND TO BE USED IN THE PRODUCTION METHOD | CDKL1, CDKL2, CDK4 | RAB9A 2725/4885HPGD 1037/4885NPC1 4885/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.